123 related articles for article (PubMed ID: 27980357)
21. Glucocorticoids regulate barrier function and claudin expression in intestinal epithelial cells via MKP-1.
Fischer A; Gluth M; Weege F; Pape UF; Wiedenmann B; Baumgart DC; Theuring F
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G218-28. PubMed ID: 24309183
[TBL] [Abstract][Full Text] [Related]
22. Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells.
Zhu H; Wang Z; Xing Y; Gao Y; Ma T; Lou L; Lou J; Gao Y; Wang S; Wang Y
J Ethnopharmacol; 2012 Jun; 141(2):714-20. PubMed ID: 21920425
[TBL] [Abstract][Full Text] [Related]
23. Mycophenolic acid mediated disruption of the intestinal epithelial tight junctions.
Qasim M; Rahman H; Ahmed R; Oellerich M; Asif AR
Exp Cell Res; 2014 Apr; 322(2):277-89. PubMed ID: 24509232
[TBL] [Abstract][Full Text] [Related]
24. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier.
Kong J; Zhang Z; Musch MW; Ning G; Sun J; Hart J; Bissonnette M; Li YC
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G208-16. PubMed ID: 17962355
[TBL] [Abstract][Full Text] [Related]
25. GYY4137 ameliorates intestinal barrier injury in a mouse model of endotoxemia.
Chen S; Bu D; Ma Y; Zhu J; Sun L; Zuo S; Ma J; Li T; Chen Z; Zheng Y; Wang X; Pan Y; Wang P; Liu Y
Biochem Pharmacol; 2016 Oct; 118():59-67. PubMed ID: 27553476
[TBL] [Abstract][Full Text] [Related]
26. Lipid rafts are disrupted in mildly inflamed intestinal microenvironments without overt disruption of the epithelial barrier.
Bowie RV; Donatello S; Lyes C; Owens MB; Babina IS; Hudson L; Walsh SV; O'Donoghue DP; Amu S; Barry SP; Fallon PG; Hopkins AM
Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G781-93. PubMed ID: 22241861
[TBL] [Abstract][Full Text] [Related]
27. Conditioned medium from LS 174T goblet cells treated with oxyresveratrol strengthens tight junctions in Caco-2 cells.
Hwang D; Jo H; Hwang S; Kim JK; Kim IH; Lim YH
Biomed Pharmacother; 2017 Jan; 85():280-286. PubMed ID: 27876210
[TBL] [Abstract][Full Text] [Related]
28. Hirsutenone reduces deterioration of tight junction proteins through EGFR/Akt and ERK1/2 pathway both converging to HO-1 induction.
Seo GS; Jiang WY; Park PH; Sohn DH; Cheon JH; Lee SH
Biochem Pharmacol; 2014 Jul; 90(2):115-25. PubMed ID: 24853984
[TBL] [Abstract][Full Text] [Related]
29. Opposing regulation of the tight junction protein claudin-2 by interferon-gamma and interleukin-4.
Wisner DM; Harris LR; Green CL; Poritz LS
J Surg Res; 2008 Jan; 144(1):1-7. PubMed ID: 17640674
[TBL] [Abstract][Full Text] [Related]
30. Moxibustion combined with acupuncture increases tight junction protein expression in Crohn's disease patients.
Shang HX; Wang AQ; Bao CH; Wu HG; Chen WF; Wu LY; Ji R; Zhao JM; Shi Y
World J Gastroenterol; 2015 Apr; 21(16):4986-96. PubMed ID: 25945013
[TBL] [Abstract][Full Text] [Related]
31. Physiologically relevant increase in temperature causes an increase in intestinal epithelial tight junction permeability.
Dokladny K; Moseley PL; Ma TY
Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G204-12. PubMed ID: 16407590
[TBL] [Abstract][Full Text] [Related]
32. [Changes in tight junction protein expression and permeability of colon mucosa in rats with dextran sulfate sodium-induced inflammatory bowel disease].
Rao YX; Chen J; Chen LL; Gu WZ; Shu XL
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec; 14(12):976-81. PubMed ID: 23234790
[TBL] [Abstract][Full Text] [Related]
33. Acute Effects of Butyrate on Induced Hyperpermeability and Tight Junction Protein Expression in Human Colonic Tissues.
Tabat MW; Marques TM; Markgren M; Löfvendahl L; Brummer RJ; Wall R
Biomolecules; 2020 May; 10(5):. PubMed ID: 32422994
[TBL] [Abstract][Full Text] [Related]
34. A CD52 antibody impairs mouse-transplanted intestinal tight junctions.
Shen B; Yu H; Yu T; Shen J; Meng N; Cai X
J Surg Res; 2015 Jun; 196(2):278-84. PubMed ID: 25796109
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic options to modulate barrier defects in inflammatory bowel disease.
Hering NA; Schulzke JD
Dig Dis; 2009; 27(4):450-4. PubMed ID: 19897959
[TBL] [Abstract][Full Text] [Related]
36. Polychlorinated biphenyls disrupt intestinal integrity via NADPH oxidase-induced alterations of tight junction protein expression.
Choi YJ; Seelbach MJ; Pu H; Eum SY; Chen L; Zhang B; Hennig B; Toborek M
Environ Health Perspect; 2010 Jul; 118(7):976-81. PubMed ID: 20299304
[TBL] [Abstract][Full Text] [Related]
37. Modified Pulsatilla decoction attenuates oxazolone-induced colitis in mice through suppression of inflammation and epithelial barrier disruption.
Wang X; Fan F; Cao Q
Mol Med Rep; 2016 Aug; 14(2):1173-9. PubMed ID: 27278299
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution.
Heller F; Florian P; Bojarski C; Richter J; Christ M; Hillenbrand B; Mankertz J; Gitter AH; Bürgel N; Fromm M; Zeitz M; Fuss I; Strober W; Schulzke JD
Gastroenterology; 2005 Aug; 129(2):550-64. PubMed ID: 16083712
[TBL] [Abstract][Full Text] [Related]
39. Effects of Bacillus subtilis on Epithelial Tight Junctions of Mice with Inflammatory Bowel Disease.
Gong Y; Li H; Li Y
J Interferon Cytokine Res; 2016 Feb; 36(2):75-85. PubMed ID: 26720180
[TBL] [Abstract][Full Text] [Related]
40. Epithelial tight junctions in intestinal inflammation.
Schulzke JD; Ploeger S; Amasheh M; Fromm A; Zeissig S; Troeger H; Richter J; Bojarski C; Schumann M; Fromm M
Ann N Y Acad Sci; 2009 May; 1165():294-300. PubMed ID: 19538319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
